Information provided by MedOp Inc.
The Age Related Eye Disease Study (AREDS) was the first major National Institutes of Health study testing nutritional supplements for treatment of age-related macular degeneration (AMD). It firmly established a therapeutic rationale for treating dry macular degeneration with supplements.
Since this original study, there have been others showing that lutein is helpful in reducing the risk of macular degenerative disease. In addition, other studies have shown that the omega-3 fatty acids EPA and DHA reduce the incidence and progression of age-related macular degeneration. In addition to visual health, the omega-3 fatty acids are also important in overall health — especially cardiovascular health. The American Heart Association recommends 1,000 mg per day of these important fatty acids.
Card’s Opticians carries MaxiVision products which are based on all current research and formulated by an Advisory Board composed of leading doctors and researchers.